Publications by authors named "Neringa Jurkute"

Article Synopsis
  • The 2022 International Consortium for Optic Neuritis introduced new diagnostic criteria using optical coherence tomography (OCT) to better assess optic neuritis, with a particular focus on intereye difference metrics in patients with MOG-associated optic neuritis (MOG-ON).
  • A multi-center study validated the diagnostic value of pre-established intereye difference cutoff values in 66 subjects, finding that metrics from the macular ganglion cell and inner plexiform layer (mGCIP) were most sensitive and specific for diagnosing MOG-ON.
  • Results indicated that OCT-based intereye difference metrics had high diagnostic accuracy for MOG-ON, especially in cases of unilateral optic neuritis, suggesting these metrics could effectively distinguish affected individuals
View Article and Find Full Text PDF

Biallelic variants in are associated with retinitis pigmentosa (RP) and Type 2 Usher Syndrome (USH2), leading to impaired vision and, additionally, hearing loss in the latter. Although the introduction of next-generation sequencing into clinical diagnostics has led to a significant uplift in molecular diagnostic rates, many patients remain molecularly unsolved. It is thought that non-coding variants or variants of uncertain significance contribute significantly to this diagnostic gap.

View Article and Find Full Text PDF
Article Synopsis
  • The article covers key visual electrodiagnostic tests used in neuro-ophthalmology, focusing on visual evoked potential (VEP) and various electroretinograms (ffERG, PERG, mfERG).
  • It illustrates how these tests help interpret conditions like optic neuropathies and retinal disorders that can mimic them, by providing specific test results for different diseases.
  • The review emphasizes the importance of using multiple electrophysiological techniques for accurate diagnosis and understanding of complex syndromic diseases.
View Article and Find Full Text PDF

Leber hereditary optic neuropathy (LHON) is a mitochondrial disease leading to rapid and severe bilateral vision loss. Idebenone has been shown to be effective in stabilizing and restoring vision in patients treated within 1 year of onset of vision loss. The open-label, international, multicenter, natural history-controlled LEROS study (ClinicalTrials.

View Article and Find Full Text PDF
Article Synopsis
  • This study focuses on understanding the genetic factors behind inherited retinal disease (IRD), a major cause of blindness, by analyzing a large cohort of patients in the UK who received molecular diagnoses from 2003 to 2020.
  • Researchers employed various genetic testing methods to identify disease-causing variants among patients, particularly examining variants in the most common IRD genes, such as ABCA4, USH2A, RPGR, PRPH2, and BEST1.
  • The findings revealed that 42.7% of families had variants in one of the five most common IRD genes, with specific insights into the prevalence and clustering of mutations in notable genes like USH2A and RPGR
View Article and Find Full Text PDF

Background: ATXN2 is the causative gene of spinocerebellar ataxia type 2 (SCA2) and has been implicated in glaucoma pathogenesis. Therefore, studying ocular changes in SCA2 could uncover clinically relevant changes.

Objective: The aim was to investigate optic disc and retinal architecture in SCA2.

View Article and Find Full Text PDF

Historically, distinct mitochondrial syndromes were recognised clinically by their ocular features. Due to their predilection for metabolically active tissue, mitochondrial diseases frequently involve the eye, resulting in a range of ophthalmic manifestations including progressive external ophthalmoplegia, retinopathy and optic neuropathy, as well as deficiencies of the retrochiasmal visual pathway. With the wider availability of genetic testing in clinical practice, it is now recognised that genotype-phenotype correlations in mitochondrial diseases can be imprecise: many classic syndromes can be associated with multiple genes and genetic variants, and the same genetic variant can have multiple clinical presentations, including subclinical ophthalmic manifestations in individuals who are otherwise asymptomatic.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore the clinical and genetic aspects of childhood-onset Leber hereditary optic neuropathy (LHON) to understand how it affects visual outcomes.
  • It included a retrospective analysis of 68 patients under 12 years old from Italy and the UK, using various ophthalmologic evaluations to assess visual loss.
  • Results indicated that children who experience visual loss before age 9 have better visual outcomes compared to those affected later, suggesting that earlier onset might correlate with a milder form of the disease.
View Article and Find Full Text PDF
Article Synopsis
  • Lenadogene nolparvovec is a novel gene therapy showing significant promise for improving visual acuity in patients with Leber hereditary optic neuropathy (LHON) who have the m.11778G>A ND4 mutation, with updated data increasing the number of treated patients from 76 to 174.
  • The therapy was compared against an external control group and resulted in a mean improvement in visual acuity of -0.30 logMAR, which is equivalent to +15 ETDRS letters, showing clinically relevant and sustained benefits over a follow-up period of up to 3.9 years.
  • Results indicate that most treated eyes retained measurable vision compared to less than half of those in the natural history group, and a
View Article and Find Full Text PDF

We report two patients, one with and one without long-term persistent tiling inside an arcuate macular scotoma. In both cases, the scotoma was caused by a cilioretinal artery occlusion. Both patients were almost identical regarding the location and extent of the scotoma.

View Article and Find Full Text PDF

The aim of this study was to investigate coenzyme Q10 (CoQ) biosynthesis pathway defects in inherited retinal dystrophy. Individuals affected by inherited retinal dystrophy (IRD) underwent exome or genome sequencing for molecular diagnosis of their condition. Following negative IRD gene panel analysis, patients carrying biallelic variants in CoQ biosynthesis pathway genes were identified.

View Article and Find Full Text PDF

The purpose of this paper is to identify likely pathogenic non-coding variants in inherited retinal dystrophy (IRD) genes, using genome sequencing (GS). Patients with IRD were recruited to the study and underwent comprehensive ophthalmological evaluation and GS. The results of GS were investigated through virtual gene panel analysis, and plausible pathogenic variants and clinical phenotype evaluated by the multidisciplinary team (MDT) discussion.

View Article and Find Full Text PDF

Objective: To evaluate the pattern of vision loss and genotype-phenotype correlations in WFS1-associated optic neuropathy (WON).

Design: Multicenter cohort study.

Methods: The study involved 37 patients with WON carrying pathogenic or candidate pathogenic WFS1 variants.

View Article and Find Full Text PDF

Background: Neurodegeneration affects the brain and peripheral nervous system in spinocerebellar ataxia type 3 (SCA3). As the retina is also involved, studying the retinal architecture in a cohort of patients could reveal clinically relevant biomarkers.

Objective: The aim is to investigate retinal architecture in SCA3 to identify potential biomarkers.

View Article and Find Full Text PDF

Purpose: To report novel genotypes and expand the phenotype spectrum of SSBP1-disease and explore potential disease mechanism.

Methods: Five families with previously unsolved optic atrophy and retinal dystrophy underwent whole genome sequencing as part of the National Institute for Health Research BioResource Rare-Diseases and the UK's 100,000 Genomes Project. In silico analysis and protein modelling was performed on the identified variants.

View Article and Find Full Text PDF

Pathogenic variants cause a rare autosomal dominant neurodevelopmental disorder referred to as the Bosch-Boonstra-Schaaf Optic Atrophy Syndrome. Although visual loss is a prominent feature seen in affected individuals, the molecular and cellular mechanisms contributing to visual impairment are still poorly characterized. We conducted a deep phenotyping study on a cohort of 22 individuals carrying pathogenic variants to document the neurodevelopmental and ophthalmological manifestations, in particular the structural and functional changes within the retina and the optic nerve, which have not been detailed previously.

View Article and Find Full Text PDF

Background/objectives: To re-evaluate diabetic papillopathy using optical coherence tomography (OCT) for quantitative analysis of the peripapillary retinal nerve fibre layer (pRNFL), macular ganglion cell layer (mGCL) and inner nuclear layer (mINL) thickness.

Subjects/methods: In this retrospective observational case series between June 2008 and July 2019 at Moorfields Eye hospital, 24 eyes of 22 patients with diabetes and optic disc swelling with confirmed diagnosis of NAION or diabetic papillopathy by neuro-ophthalmological assessment were included for evaluation of the pRNFL, mGCL and mINL thicknesses after resolution of optic disc swelling.

Results: The mean age of included patients was 56.

View Article and Find Full Text PDF

This work aimed to compare the evolution of visual outcomes in Leber hereditary optic neuropathy (LHON) patients treated with intravitreal gene therapy to the spontaneous evolution in prior natural history (NH) studies. A combined analysis of two phase three randomized, double-masked, sham-controlled studies (REVERSE and RESCUE) and their joint long-term extension trial (CLIN06) evaluated the efficacy of rAAV2/2- vs. 11 pooled NH studies used as an external control.

View Article and Find Full Text PDF

Biallelic mutations in , encoding the mitochondrial aconitase 2, have been identified in individuals with neurodegenerative syndromes, including infantile cerebellar retinal degeneration and recessive optic neuropathies (locus OPA9). By screening European cohorts of individuals with genetically unsolved inherited optic neuropathies, we identified 61 cases harbouring variants in , among whom 50 carried dominant mutations, emphasizing for the first time the important contribution of monoallelic pathogenic variants to dominant optic atrophy. Analysis of the ophthalmological and clinical data revealed that recessive cases are affected more severely than dominant cases, while not significantly earlier.

View Article and Find Full Text PDF

Purpose: The purpose of this study was to report retinal dystrophy as a novel clinical feature and expand the ocular phenotype in patients harboring biallelic candidate FDXR variants.

Methods: Patients carrying biallelic candidate FDXR variants were identified by whole genome sequencing (WGS) as part of the National Institute for Health Research BioResource rare-disease and the UK's 100,000 Genomes Project (100KGP) with an additional case identified by exome sequencing. Retrospective clinical data were collected from the medical records.

View Article and Find Full Text PDF

Background/objectives: REALITY is an international observational retrospective registry of LHON patients evaluating the visual course and outcome in Leber hereditary optic neuropathy (LHON).

Subjects/methods: Demographics and visual function data were collected from medical charts of LHON patients with visual loss. The study was conducted in 11 study centres in the United States of America and Europe.

View Article and Find Full Text PDF